Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Oxidative Stress
2017 Standout
The discovery and development of HMG-CoA reductase inhibitors.
1992
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Sirtuins as regulators of metabolism and healthspan
2012 Standout
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
No health without mental health
2007 Standout
Season of Birth in Schizophrenia
1991
Bioinformatics for protein biomarker panel classification: what is needed to bring biomarker panels intoin vitrodiagnostics?
2009
Characterization of lipid and lipoprotein metabolism in primary human hepatocytes
2012
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Influence of Metabolism on Epigenetics and Disease
2013 StandoutNobel
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Niacin and cholesterol: role in cardiovascular disease (review)
2003
Nicotinic acid induces secretion of prostaglandin D2 in human macrophages: An in vitro model of the niacin flush
2006
Biochemical and toxicological properties of the oxidation products of catecholamines
1992
Treatment of Alcoholism Using Psychedelic Drugs: A Review of the Program of Research
1998
Activation of Gpr109a, Receptor for Niacin and the Commensal Metabolite Butyrate, Suppresses Colonic Inflammation and Carcinogenesis
2014 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Rapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1
2011
NAD+ as a Signaling Molecule Modulating Metabolism
2011
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
2015
Psychedelics
2016 Standout
GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
2005
Nicotinic acid: an old drug with a promising future
2007
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
2009 Standout
Drug Treatment of Lipid Disorders
1999
Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
1992 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
The Pharmacology of Lysergic Acid Diethylamide: A Review
2008
Interactive Effects of the Affect Quality and Directional Focus of Mental Imagery on Pain Analgesia
2001
Diabetes and Atherosclerosis
2002 Standout
Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research
1992
pROC: an open-source package for R and S+ to analyze and compare ROC curves
2011 Standout
Niacin in cardiovascular prevention: mechanisms, efficacy, and safety
2007
Poly(ADP-ribose): novel functions for an old molecule
2006 Standout
The Benefits of Frequent Positive Affect: Does Happiness Lead to Success?
2005 Standout
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
The weirdest people in the world?
2010 Standout
Mortality in Offspring of Parents With Psychotic Disorders: A Critical Review and Meta-Analysis
2005
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
2009 StandoutNobel
The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function
2003 Standout
Effect of Niacin on Lipid and Lipoprotein Levels and Glycemic Control in Patients With Diabetes and Peripheral Arterial Disease
2000
The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions
2003 Standout
Effects of perinatal mental disorders on the fetus and child
2014 Standout
Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
2011
Psilocybin-Occasioned Mystical Experiences in the Treatment of Tobacco Addiction
2015
Discoveries of Nicotinamide Riboside as a Nutrient and Conserved NRK Genes Establish a Preiss-Handler Independent Route to NAD+ in Fungi and Humans
2004
Niche construction, biological evolution, and cultural change
2000
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
2013 StandoutNature
Safety Considerations with Niacin Therapy
2006
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
2005
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies
2007
Use of antioxidant supplements during breast cancer treatment: a comprehensive review
2008
Physiological Dysfunction of the Dorsolateral Prefrontal Cortex in Schizophrenia Revisited
2000
New Insights on NOX Enzymes in the Central Nervous System
2013
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Oxidants, antioxidants, and the degenerative diseases of aging.
1993 Standout
Psychedelic Agents in Creative Problem-Solving: A Pilot Study
1966
Orthomolecular Psychiatry
1968 Science
On the Use and Abuse of LSD
1968
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Factors affecting lipoprotein metabolism.
1965
The highly pleiotropic gene SLC39A8 as an opportunity to gain insight into the molecular pathogenesis of schizophrenia
2017
Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients
2005
Effects of Amino Acid Feedings in Schizophrenic Patients Treated with Iproniazid
1961 Science
Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance.
1996 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Problems with Instrumental Variables Estimation when the Correlation between the Instruments and the Endogenous Explanatory Variable is Weak
1995 Standout
Sensory Neuropathy from Pyridoxine Abuse
1983 Standout
‘Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970
2006
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction
2014
Total Synthesis of α-Pyrone Meroterpenoids, Novel Bioactive Microbial Metabolites
2005 StandoutNobel
Serum Cholesterol, Lipoproteins, and the Risk of Coronary Heart Disease
1971 Standout
Human serum leads to differentiation of human hepatoma cells, restoration of very-low-density lipoprotein secretion, and a 1000-fold increase in HCV Japanese fulminant hepatitis type 1 titers
2013 StandoutNobel
Nicotinic Acid: Pharmacological Effects and Mechanisms of Action
2007
Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences?
2015
Ascorbic Acid-Induced Uricosuria
1976
Spermidine in health and disease
2018 StandoutScience
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Cutting a Gordian knot in the linkage analysis of complex human traits.
1990
Adopt a moratorium on heritable genome editing
2019 StandoutNatureNobel
Human hallucinogen research: guidelines for safety
2008
Prediction of stroke outcome with echoplanar perfusion- and diffusion-weighted MRI
1998
Microwave-Assisted Synthesis in Water as Solvent
2007 Standout
1-Alkyl-benzotriazole-5-carboxylic Acids Are Highly Selective Agonists of the Human Orphan G-Protein-Coupled Receptor GPR109b
2006
Niacin Decreases Removal of High-Density Lipoprotein Apolipoprotein A-I But Not Cholesterol Ester by Hep G2 Cells
1997
Somatic and behavioural postnatal effects of fetal injections of nerve growth factor antibodies in the rat
1981 StandoutNatureNobel
Niacin, but Not Gemfibrozil, Selectively Increases LP-AI, a Cardioprotective Subfraction of HDL, in Patients With Low HDL Cholesterol
2001
Genetic Dissection of Complex Traits
1994 StandoutScience
The role of nerve-growth factor (NGF) in the central nervous system
1976
Dietary and Drug Treatment of Primary Hyperlipoproteinemia
1972
Effects of Mescaline, LSD-25, and Adrenochrome on Depth Electrograms in Man
1956
Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment
1983
Genetic Theorizing and Schizophrenia
1973
Studies on the Role of Adenosine 3',5'-Monophosphate in the Hepatic Actions of Glucagon and Catecholamines
1971 StandoutNobel
Studies on the Effect of Nicotinic Acid on Catecholamine Stimulated Lipolysis in Adipose Tissue in Vitro
1963
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
2008
Coma, hyperthermia and bleeding associated with massive LSD overdose. A report of eight cases.
1974
Oxidative stress and cancer: have we moved forward?
2006
Hypercholesteremia and nicotinic acid
1961
Enzymatic Formation of Psychotomimetic Metabolites from Normally Occurring Compounds
1961 StandoutScienceNobel
A polygenic theory of schizophrenia.
1967
Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose a Report of Eight Cases
1975
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
A REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS
1957
Current Metabolic-Genetic Interrelationship in Human Atherosclerosis
1968
Nicotinic Acid Maculopathy
1973
The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
2010
Exploring the therapeutic space around NAD+
2012
The Effects of Megadoses of Selected B Complex Vitamins on Children with Hyperkinesis
1982
Works of A. Hoffer being referenced
Mega-Dose Vitamins and Minerals in the Treatment of Non-Metastatic Breast Cancer: An Historical Cohort Study
2002
Drug-Induced Schizophrenia
1960
Reliability of the Hoffer-Osmond diagnostic test
1967
Schizophrenia: A New Approach. II. Result of a Year's Research
1954
Schizophrenia as a Genetic Morphism
1965 Nature
A card sorting test helpful in making psychiatric diagnosis.
1961
Nicotinic Acid Modified Lysergic Acid Diethylamide Psychosis
1955
THE ADRENOCHROME MODEL AND SCHIZOPHRENIA1
1959
Use of d-Lysergic Acid Diethylamide in the Treatment of Alcoholism
1959
A small research in schizophrenia.
1959
TREATMENT OF SCHIZOPHRENIA WITH NICOTINIC ACID A Ten Year Follow‐up1
1964
Elevated Creatine Phosphokinase Activity
1971
The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study.
1966
The Effect of Nicotinic Acid on Hypercholesterolaemia.
1960
EFFECT OF ATROPINE ON BLOOD PRESSURE OF PATIENTS WITH MENTAL AND EMOTIONAL DISEASE
1954
D‐Lysergic acid diethylamide (LSD): A review of its present status
1965
Treatment of schizophrenia with nicotinic acid and nicotinamide.
2002
Schizophrenia as a Genetic Morphism
1964 Nature
The chemical basis of clinical psychiatry
1960
Some psychological consequences of perceptual disorder and schizophrenia.
1966
THE EFFECT OF ADRENOCHROME AND NIACIN ON THE ELECTROENCEPHALOGRAM OF EPILEPTICS
1955
Influence of nicotinic acid on serum cholesterol in man
1955
Design and planning in psychiatric research as illustrated by the Weyburn chronic nucleotide project.
1954
The effect of nicotinic acid upon serum cholesterol and upon basal metabolic rate of young normal adults
1958
Effect of nicotinic acid on liver function and leukocytes.
1959
The Hypocholesterolemic Effect of Nicotinic Acid and its Relationship to the Autonomic Nervous System
1957
A CARD SORTING TEST HELPFUL IN ESTABLISHING PROGNOSIS
1962